Clinical trial
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or…
NCT00351611 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00351611 |
|---|---|
| Title | Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo |
| Official title | PROSPECTIVE RANDOMIZED 12-WEEK CONTROLLED STUDY OF VISUAL FIELD CHANGE IN SUBJECTS WITH PARTIAL SEIZURES RECEIVING PREGABALIN OR PLACEBO |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsies, Partial |
| Intervention type | Drug |
| Interventions | Lyrica (pregabalin), placebo |
| Enrollment | 187 |
| Start date | Jul 26, 2006 |
| Primary completion | Feb 4, 2020 |
| Completion | Feb 4, 2020 |
| First posted | Jul 13, 2006 |
| Last update posted | Apr 13, 2021 |
| Countries | Bulgaria, Czechia, Hungary, India, Mexico, Poland, South Korea, Thailand, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: